SKI Market

Indian Indices

Nifty

24,834.85 428.75
(1.76%)

Sensex

81,332.72 1,292.92
( 1.62%)

Bank Nifty

51,295.95 407.20
( 0.80%)

Nifty IT

40,977.35 921.90
( 2.30%)

Global Indices

Nasdaq

17,181.72 -160.69
(-0.93%)

Dow Jones

39,935.07 81.20
(0.20%)

Hang Seng

17,021.31 16.34
(0.10%)

Nikkei 225

37,667.41 -202.10
(-0.53%)

Forex

USD-INR

83.71 0.03
(0.04%)

EUR-INR

90.78 -0.15
(-0.16%)

GBP-INR

108.02 -0.04
(-0.04%)

JPY-INR

0.54 0.01
(1.18%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

ANG Lifesciences India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540694

INE236W01016

59.0263386

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

65.45

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)	Mar 2018 ( Cr)
Sales Turnover	207.01	348.67	154.28	126.83	121.70	76.04
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	207.01	348.67	154.28	126.83	121.70	76.04
Other Income	9.84	0.95	0.75	0.42	0.23	0.69
Stock Adjustments	4.22	4.47	4.30	0.59	1.05	0.32
Total Income	221.07	354.09	159.33	127.84	122.98	77.05
EXPENDITURE :
Raw Materials	151.12	234.49	108.26	89.56	88.89	53.21
Power & Fuel Cost	5.99	5.68	4.88	3.66	2.71	1.73
Employee Cost	20.27	18.32	14.35	7.10	6.39	5.64
Other Manufacturing Expenses	1.85	2.96	1.60	1.03	0.80	0.63
Selling & Administrative Expenses	18.21	23.49	13.56	10.60	8.73	6.53
Miscellaneous Expenses	2.12	2.65	0.59	3.04	3.58	1.31
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	199.56	287.60	143.24	114.99	111.10	69.06
Operating Profit	21.51	66.49	16.08	12.85	11.87	7.99
Interest	10.92	8.31	3.98	3.22	2.64	1.85
Gross Profit	10.59	58.18	12.10	9.63	9.23	6.14
Depreciation	8.52	5.12	2.24	1.23	1.12	1.19
Profit Before Tax	2.07	53.06	9.86	8.40	8.11	4.95
Tax	2.11	13.47	3.18	2.40	2.43	1.03
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.62	-0.11	-0.57	-0.09	0.03	0.19
Reported Net Profit	-0.66	39.71	7.25	6.10	5.65	3.72
Extraordinary Items	-0.27	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	-0.39	39.71	7.25	6.10	5.65	3.72
Adjustment below Net Profit	0.72	0.21	-0.70	-0.26	0.00	0.00
P & L Balance brought forward	63.10	24.22	17.67	13.03	7.38	3.66
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	1.04	0.00	0.00	0.00	0.00
P & L Balance carried down	63.16	63.10	24.22	18.87	13.03	7.38
Dividend	0.00	1.04	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	10.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	1.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-0.51	38.31	13.99	11.76	10.90	7.18
Earnings Per Share(Adj)-Unit Curr	-0.51	30.65	5.60	4.70	4.36	2.87
Book Value-Unit Curr	61.91	76.00	76.99	66.67	55.50	44.70
Book Value(Adj)-Unit Curr	61.91	60.80	30.80	26.67	22.20	17.88

24,834.85 428.75 (1.76%)

81,332.72 1,292.92 ( 1.62%)

51,295.95 407.20 ( 0.80%)

40,977.35 921.90 ( 2.30%)

17,181.72 -160.69 (-0.93%)

39,935.07 81.20 (0.20%)

17,021.31 16.34 (0.10%)

37,667.41 -202.10 (-0.53%)

83.71 0.03 (0.04%)

90.78 -0.15 (-0.16%)

108.02 -0.04 (-0.04%)

0.54 0.01 (1.18%)